The synthesis of new isonucleosides comprising purine and pyrimidine-derived systems linked to methyl glucopyranosidyl units at C-6 and evaluation of their cholinesterase inhibitory profiles is reported. Their access was based on the Mitsunobu coupling of partially acetylated and benzylated methyl glucopyranosides with purine and pyrimidine derivatives. While the reactions with purines and theobromine proceeded with complete regioselectivity, affording exclusively N -bis-glucopyranosid-6-yl thymine were the most active molecules with K i values of 4 μM. A tri-O-benzylated glucopyranosid-6′-yl uracil displayed good and selective inhibition of butyrylcholinesterase (K i = 8.4 ± 1.0 μM), similar to that exhibited by the standard galantamine. Molecular docking simulations, performed with the two most effective acetylcholinesterase inhibitors, showed interactions with key amino acid residues located at the enzyme's active site gorge, which explain the competitive component of their inhibitory activities.
Introduction
Nucleoside analogs and modified nucleosides have attracted considerable interest in the search for promising therapeutically-relevant molecules, owing to their variety of biological activities. Such compounds have the propensity to be incorporated into nucleic acids and to compete with natural nucleosides as substrates for enzymes involved in key physiological processes such as nucleic acid synthesis or cell division. These mechanisms induce inhibition of viral replication or cytotoxicity which leads to antiviral or antitumor effects [1] . Antibacterial and antifungal properties have also been extensively reported for this class of compounds, arising from their inhibitory effect on microbial cell wall assembly and on nucleic acid or protein synthesis [2] [3] [4] [5] [6] . Some few recent studies showed the ability of nucleoside analogs to inhibit cholinesterases [7] [8] [9] , enzymes that catalyze the hydrolysis of the neurotransmitter acetylcholine and remain major targets for Alzheimer's disease therapy [10, 11] . The described compounds include benzylated mannosyl purine nucleosides, which showed potent and selective activity towards butyrylcholinesterase [8] and purine nucleosides of d-glucuronic acid derivatives, with selective effect on acetylcholinesterase [9] .
Among nucleoside analogs, those comprising the nucleobase linked to a position other than C-1 of the carbohydrate moiety, i.e. isonucleosides, are attractive synthetic targets since their C-N bond is more stable to enzymatic and chemical hydrolysis than the N-glycosidic bond (N-C1′) in nucleosides. Moreover, such compounds have been reported as possessing antitumor [12, 13] and antiviral properties [14] [15] [16] [17] [18] [19] . Included in the antiviral isonucleosides, are isodideoxyadenosine [14] and its (S,S)-isomer [17] , described as being effective towards immunodeficiency virus (HIV), and BMS-181165, which showed potent activity against varicellazoster virus (VZV) [16] . d-and l-Isonucleosides [20, 21] and deoxy-or dideoxy derivatives are reported [13, 15, 19, [22] [23] [24] , most of them comprising the nucleobase linked at C-2 or C-3 of furanosyl systems, namely 1,4-anhydroalditol moieties [18] . The search for new and structurally diverse isonucleosides and the exploitation of novel biological properties for this class of nucleoside analogs remains of interest.
In this context, we have previously focused on pyranosyl 6′-isonucleosides, namely glycopyranos-6′-yl purines and an aminomethyltriazole 6′-isonucleoside (1, Fig. 1 ), which were synthesized by regioselective Mitsunobu coupling and by a 'click chemistry' approach, respectively [25] . Their bioactivity assessment, particularly the evaluation of their enzyme inhibitory effects, revealed a selective and moderate inhibition of acetylcholinesterase by a mannopyranosid-6′-yl guanine and by the triazole 6′-isonucleoside 1, which was the best inhibitor with a K i value of 11.9 μM (Fig. 1) .
These results prompted us to synthesize analogs of isonucleoside 1, maintaining the methyl α-dglucopyranosidyl backbone while varying the N-heteroaromatic unit and the substitution pattern of the sugar moiety, aiming at their screening for ChEs inhibitory abilities and attaining enhanced effects towards these targets.
The methods reported for the synthesis of isonucleosides include the introduction of nucleobases at the sugar moiety through nucleophilic displacement of an activated hydroxyl group [19, 23] , opening of an epoxide [13] or a cyclic sulfate [26] or via Mitsunobu coupling [24] . Another strategy involves the construction of the nucleobase unit on the sugar backbone from azido or amino sugars [19, 27] . The Mitsunobu reaction is a more convenient method since the alcohol, in this case, the partially protected sugar, is activated and coupled in situ under mild and neutral conditions to the nucleobase, with complete regioselectivity using purine derivatives [24, 25] . The other methodologies, besides requiring more steps, often lead to regioisomeric mixtures and modest yields. We describe herein the synthesis of 6′-isonucleosides using the Mitsunobu reaction of partially acetylated and benzylated methyl glucopyranoside containing a free hydroxyl group at C-6 with purine and pyrimidine derivatives as key step. Results on the evaluation of their cholinesterase inhibitory effects are presented. Molecular docking studies were performed allowing inspecting the binding modes of the most active compounds to the enzyme.
Results and discussion
Methyl tri-2,3,4-O-acetyl-α-d-glucopyranoside (2) and methyl tri-2,3,4-O-benzyl-α-d-glucopyranoside (3) were the precursors for the introduction of purine and pyrimidine nucleobases into C-6, aiming at studying the effect that the acetyl and benzyl groups, which create different steric environments at the sugar moiety, have on the outcome of the Mitsunobu reaction as well as on the ChE inhibitory abilities of the resulting isonucleosides.
The direct coupling reactions of methyl α-d-glucopyranoside with a purine (2-acetamido-6-chloropurine) and with a pyrimidine (uracil) at C-6 were also attempted, encouraged by previous reports on the regioselective derivatization of deprotected sugars at primary hydroxyl groups under Mitsunobu conditions [28] [29] [30] [31] . However, this approach appeared not to be feasible, since these preliminary experiments showed virtually no conversion at room temperature after 16 h and the formation of inseparable complex mixtures of unwanted sugar derivatives, not comprising the heteroaromatic nucleous, at higher temperatures (55-60 °C), while ca. 70 % of the starting material remained unreacted after 16 h.
For the synthesis of purine 6′-isonucleosides starting from 2 to 3, 2-acetamido-6-chloropurine, adenine and theobromine were the purine derivatives used (Scheme 1). In the previous report [25] , the reaction of 2 with 2-acetamido-6-chloropurine (in excess, 2 equiv.), in the presence of diethyl azodicarboxylate (DEAD) and triphenylphosphine (both 2 equiv.) at room temp., afforded solely the N 9 -linked isonucleoside 4, the hydrolysis of which using aqueous trifluoroacetic acid (TFA) gave the methyl glucopyranosid-6′-yl guanine 6. Both 4 and 6 did not show significant effect on ChEs. In the present work, the Mitsunobu reaction employing 3, under similar conditions as for 2, led to the N 9 -isonucleoside 5 in 59 % yield. The N9-C6′-linkage of 5 was clearly assigned based on its HMBC spectrum, in which a correlation between both H-6′ of the sugar unit and C-4 of the purine moiety was observed. Hydrogenation of 5 in the presence of 10 % Pd/C effected both debenzylation and dechlorination leading to 7.
The coupling of tri-O-protected glucopyranosides 2 and 3 with adenine furnished the corresponding N 9 -glucopyranosid-6′-yl adenines 8 and 9 in moderate yields (33 % and 36 %, respectively), the regiochemistry of both being determined by the HMBC correlations between H-6′ and both C-4/C-8. Mitsunobu adducts arising from the free C-6 adenine amino group were not formed. The lower conversions obtained with adenine may be due to its poor solubility in THF. There are very few successful reports on the Mitsunobu reaction involving free adenine and those deal with the coupling of this nucleobase with cyclic alcohols in the context of the synthesis of carbocyclic nucleoside analogs [32, 33] . The access to a deprotected adenine 6′-isonucleoside (10) was achieved by deacetylation of 8 under acidic conditions (aq. TFA).
The purine alkaloid theobromine (3,7-dimethyl-1H-purine-2,6-dione), a xanthine derivative, was also selected as a nucleobase for the coupling to 2-3. The synthesis and study of the biological profile of xanthine nucleosides and analogs is a relatively unexploited topic. Few examples of such molecules are known, which include the naturally occurring xanthosine, a precursor in the biosynthesis of caffeine [34, 35] , and synthetic compounds such as N 1 -(tetra-O-acetylglucosyl)theobromine [36] and anhydro isoxanthosine derivatives possessing antiviral efficacy [37, 38] . Moreover, xanthine derivatives were recently described as selective AChE inhibitors [39, 40] which encouraged us to undertake the synthesis of xanthine isonucleosides and further evaluate their effect towards ChEs. Hence, treatment of glucopyranosides 2 and 3 with theobromine under the previously mentioned Mitsunobu conditions provided the N 1 -glucopyranosid-6′-yl theobromines 11 and 12 in 27 % and 48 % yield, respectively. The N-substitution in 11-12 was confirmed by their 13 C NMR spectra, in which the signals for C-6′ appeared at 41.8 and 42.5 ppm, and by the HMBC experiments due to the correlations observed between H-6′ and C-2/C-6. Compound 11 was further deacetylated using aq. TFA to give the related deprotected isonucleoside 13.
To the best of our knowledge, there is only one report to date on the N 1 -functionalization of a xanthine scaffold with alcohols using the Mitsunobu reaction, in which the nucleobase was anchored to a solid support for the coupling [41] . Compounds 11-13 constitute the first examples of theobromine isonucleosides.
Uracil and thymine were the nucleobases used for the access to pyrimidine 6′-isonucleosides using the above-mentioned methodology. The Mitsunobu reaction between 2 and uracil (Scheme 2) proceeded with bis-coupling at the N 1 and N 3 positions, which was followed by acid-mediated hydrolysis to afford the deprotected uracil-linked pseudodisaccharide 14 in 36 % overall yield. The intermediate acetylated Mitsunobu adduct could not be separated from the triphenylphosphine oxide by-product using column chromatography. Assignment of the N 1 ,N 3 -regiochemistry of 14 was supported by the key HMBC correlations between H-6′ protons and C-2/C-4 and between H-6″ and C-2/C-6. In the 13 C spectrum, the signals for C-6′ and C-6″ were observed at 43.8 and 51.6 ppm, respectively. The structure of 14 is also interesting for further biological assays. Some heteroaromatic-linked disaccharide analogs have been synthesized [25, [42] [43] [44] [45] [46] , some of them displaying significant bioactivities [25, 44, 45] . A guanine-linked pseudodisaccharide framework is contained in Guanofosfocins, promising antifungal natural cyclic nucleotide analogs acting as strong inhibitors of chitin synthases [47] . Analogs of such structure have been prepared [48] [49] [50] .
In contrast to 2, when the partially benzylated glucopyranoside 3 was reacted with uracil, the major product The lower conversion and the different reaction outcome when using the benzylated precursor 3 probably arise from the steric hindrance caused by the benzyloxy groups, namely those at C-3 and C-4, which deters the formation of the transient oxyphosphonium ion and the subsequent nucleophilic attack from the incoming deprotonated nucleobase. Since the deprotonated N1-H function is the most nucleophilic center of uracil [51] -disubstituted derivative 17 and therefore products of mono-coupling (18, 19) are also formed in a significant amount.
The steric effect was even more pronounced with the tri-O-benzylated glucopyranoside 3. Its reaction with thymine hardly proceeded at room temperature and was carried out at 40 °C to give the N 1 -glucopyranosid-6′-yl thymine 22 as major product (44 % 
21.
Compounds 20-23 presented identical NMR features, namely the diagnostic HMBC correlations, as those observed for the previous analogs in accordance with the assigned regiochemistry.
All the protected and deprotected isonucleosides, including the pseudodisaccharide derivatives, were evaluated for their cholinesterase inhibitory activities towards acetylcholinesterase (AChE, from Electrophorus electricus) and butyrylcholinesterase (BChE, from equine serum) using the Ellman's method. The therapeutically-used ChE inhibitor, galantamine hydrobromide, was used as standard. Compounds' inhibition constants K i (for a competitive inhibition) or K i ′ (for an uncompetitive inhibition) and the type of inhibition are given in Table 1 .
Among the purine isonucleosides, while the previously reported acetylated 2-acetamido-6-chloro-9-glucopyranosid-6′-yl purine (4) [25] did not show significant inhibitory activity on both ChEs, its benzylated counterpart 5 exhibited a selective and good mixed-type inhibition of AChE (K i ′ = 7.1 ± 0.3 μM), in which the uncompetitive component is predominant (K i ′ < K i ). Isonucleoside 7, containing a 2-N-acetyl purine moiety N 9 -linked to the deprotected methyl glucopyranoside backbone did not show any activity, a similar result to that previously obtained for a related isonucleoside 6 comprising a 2-N-acetyl guanine moiety.
With respect to the adenine isonucleosides, the tri-O-acetylated derivative 8 and the deprotected analog 10 were devoid of any significant inhibitory activities on both ChEs. The inhibition constants for the related tri-O-benzylated isonucleoside 9 could not be specifically determined due to low solubility of the compound at concentrations above 2 μm, bellow which no appreciable AChE and of BChE inhibition was detected. Owing to solubility limitations, K i values for other benzylated isonucleosides, such as 12, 15, 16, 22, 23, could not be obtained, whose maximal concentrations tested were too low for significant inhibitory effects to be noticeable.
From the theobromine isonucleosides, the acetylated derivative 11 was the best ChE inhibitor and also one of the most active compounds of this series. It exhibited the highest selectivity for AChE and a mixed-type inhibition towards this enzyme, with a pronounced competitive character that dominates the uncompetitive one with 15.4 fold smaller K i (4.3 ± 0.8 μM) compared to K i ′ (66.3 ± 12.2 μM). Concerning the pyrimidine isonucleosides, the only significantly active monosubstituted pyrimidine derivative was the tri-O-benzylated glucopyranosid-6-yl uracil (16) which was the only compound that caused a significant and slight selective inhibition of BChE. It was found to be a good BChE inhibitor acting by a competitive mechanism with an identical K i value (8.4 ± 1.0 μM) to that of galantamine hydrobromide. BChE inhibition may provide additional benefits in the treatment of Alzheimer's disease (AD). Although most attention has been paid to AChE as target, the brain levels of this enzyme progressively decrease in AD, while those of BChE increase, and hence regulation of the concentration of the neurotransmitter acetylcholine becomes increasingly dependent on BChE [52] . Thus, dual AChE/BChE inhibition as well as selective BChE inhibitors potentially offer more sustained efficacy in advanced AD.
Two of the pyrimidine-linked disaccharides were shown to selectively inhibit AChE, namely the N 1 ,N 3 -bisglucopyranosid-6-yl uracil (14) with moderate competitive effect (K i = 22.9 ± 6.3 μM) and the benzylated N 1 ,N 3 -bis-glucopyranosid-6-yl thymine (20) , a mixed-type inhibitor with similar K i value than that of 11. Despite the large size of 20, the competitive contribution for its inhibitory effect is predominant. However, its K i ′ value (9.3 ± 0.4 μM) is lower than that of 11, indicating a more significant uncompetitive behaviour for the enzyme inhibition relatively to that exhibited by 11.
In order to understand, at the molecular level, the interaction of these novel inhibitors with AChE, namely those accounting for the competitive component of their inhibitory effects, flexible molecular docking was performed using the two most active compounds (11 and 20) with the open-source program AutoDock Vina 1.1.2 [53] . The crystal structure of AChE was retrieved from the RCSB Protein Data Bank (PDB: 1B41) [54] whereas 3D models of compounds 11 and 20 were built using Pymol [55] . Residues Tyr124, Trp286, Tyr337, and Tyr341 of 1B41 were considered flexile in all calculations.
In Fig. 2 , the main interactions of 11 and 20 with the residues of the binding pocket of the enzyme are depicted for the most stable binding poses computed with AutoDock Vina.
The thymine-linked pseudodisaccharide 20, shown to be the most active compound, is able to enter the enzyme binding pocket in spite of its large size, in agreement with the experimentally determined more 
Pyrimidine 6′-isonucleosides Glucopyranosid-6′-yl pyrimidines 1 [25] 11.9 ± 1.6 (competitive)
> 100
Purine 6′-isonucleosides 16 > 10 8.4 ± 1.0 (competitive) 4 [25] > 100 > 100 competitive character of its mixed-type inhibitory activity. Inside the binding pocket, some phenyl rings of the benzyl groups are involved in π-stacking interactions with AChE residues. In fact, the best docking solution shows a successive chain of π···π interactions consisting of a Bn···Tyr341···Bn···Tyr337 π-stacking interaction. This stacking allows compound 20 to fit the cavity, being one of the monosaccharide units positioned towards the anionic subsite of the enzyme and the other at the entrance to the active site gorge. The binding inside the AChE gorge is further enhanced by the presence of a N-H···O hydrogen bond between Phe295, an amino acid residue located at the acyl pocket, and a carbonyl group of the pyrimidine core of 20. The Tyr341 residue at the peripheral anionic site, engaged in the π-stacking interactions, is also "locked" by the presence of two hydrogen bonds with Asp74 and Tyr72. Concerning the theobromine isonucleoside 11, a π-stacking interaction is formed between the purine core and Trp86, a key residue for substrate binding located at the anionic subsite. This type of interaction was previously reported for the analogous triazole isonucleoside 1 [25] , thus further confirming this binding mode. Moreover, Phe295 is involved in an N-H···O hydrogen bond with an acetate carbonyl group of the sugar moiety. Residues Asp74 and Tyr337 are also involved in close contacts. The role of these residues was also of great importance for the triazole isonucleoside 1 [25] .
In agreement with the AChE inhibition studies, AutoDock Vina qualitatively predicted the correct binding affinity with calculated binding energies of -12.7 and -9.8 kcal mol −1 for 20 and 11, respectively, thus further supporting the docking results. 
Conclusions
In summary, the synthesis of a series of new types of isonucleosides by the Mitsunobu coupling between a nucleobase and glucopyranosides containing a free hydroxyl group at C-6 has been described. For the reactions involving pyrimidine nucleobases, it was shown that both the substituents located on the sugar core and the nature of the nucleobase are important structural factors in directing the formation of N 1 /N 3 -glucopyranosid-6′-yl pyrimidines or the bis-coupling at N 1 , N 3 or at 2-O, 4-O of the pyrimidine system leading to pseudodisaccharides. Hence, when using the benzylated sugar precursor, even though the primary hydroxyl is rather accessible, the benzyloxy groups at C-3 and C-4 cause steric hindrance in the intermediate oxyphosphonium ion as well as in the reaction transition state. Therefore, products of monocoupling were predominantly formed. On the other hand, the presence of acetyl groups in the sugar moiety does not hamper the formation of N 1 ,N 3 -pyrimidine-linked disaccharides, which was in fact the sole Mitsunobu adduct obtained when using uracil. An additional methyl group at C-5 of the pyrimidine nucleous, proved to be enough to increase the steric constrains to the formation of the N 1 ,N 3 -bis-glucopyranosidyl pyrimidine, and hence the yield on this product was lowered when thymine was used.
The cholinesterase inhibition assays revealed five molecules of significant inhibitory effects. Three of them (5, 11 and 20) were more active towards AChE than the previously reported triazole 6′-isonucleoside 1 that motivated this study. In particular, the acetylated theobromine 6′-isonucleoside 11 and the benzylated thymine-linked disaccharide 20 showed the lowest K i values (4 μM) for selective and mixed-type AChE inhibition, which turn them promising lead compounds for further research. The benzylated glucopyranosid-6′-yl uracil 16 was the only active compound towards BChE, as slight selective and competitive inhibitor with a K i value comparable to that of galantamine, a clinically-used compound for the treatment of Alzheimer's disease. The uracil-linked disaccharide 14 was the only deprotected molecule of this series that showed significant inhibitory activity, with moderate and selective effect on AChE.
The results obtained indicate that the sugar substituents as well as the nucleobase moiety are crucial for the biological efficacy. This was indeed supported by the docking studies using the two most active compounds, which showed interactions arising from the nucleobase and from the sugar substituents with crucial amino acid residues for enzyme-substrate recognition.
In conclusion, this study demonstrated the ability of 6′-isonucleosides to exhibit inhibitory efficacy towards ChEs, which broadens the knowledge on the biological profile of isonucleosides and opens new potential therapeutic applications for this class of nucleoside analogs.
Experimental section Chemistry General methods
All reactions were monitored by TLC on Merck 60 F254 silica gel aluminium plates with detection under UV light (254 nm) and/or by spraying with a solution of 10 % H 2 SO 4 in EtOH or with a solution of 0.2 % (w/v) cerium(IV) sulphate-5 % ammonium molybdate in 6 % aq. H 2 SO 4 (Hanessian stain). Column chromatography was carried out on silica gel 60 (0.040-0.063 mm, Merck). NMR spectra were acquired with a Bruker Avance 400 spectrometer operating at 400.13 MHz for 1 H NMR and 100.62 MHz for 13 C NMR. Chemical shifts are expressed in ppm and are reported relative to internal TMS, in the case of CDCl 3 , or relative to the respective solvent peak as reference. High-resolution mass measurements were performed on a High Resolution QqTOF Impact II mass spectrometer equipped with an ESI ion source from Bruker Daltonics. Spectra were acquired in positive ESI mode with external calibration. Optical rotations were measured with a Perkin-Elmer 343 polarimeter at 25 °C (589 nm, sodium D line). Melting points were determined with a Stuart Scientific SMP 3 apparatus and are uncorrected.
General procedure for the Mitsunobu coupling of methyl 2,3,4-tri-O-acetyl/benzyl-α-d-glucopyranoside with purine/pyrimidine nucleobases
To a solution of partially deprotected methyl α-d-glucopyranoside (0.215 mmol) in THF (5 mL), under nitrogen atmosphere, PPh 3 (113 mg, 0.43 mmol), diethyl azodicarboxylate (DEAD; 0.43 mmol, 0.07 mL) and purine/ pyrimidine derivative (0.43 mmol) were sequentially added. The mixture was stirred under the conditions indicated further. The solvent was evaporated and the crude was subjected to column chromatography on silica-gel. -6-chloro-9-(methyl 2,3,4-tri-O-benzyl-6-deoxy-α-d-glucopyranosid-6-yl) Dimethyl-3,7-dihydro-1-(methyl 2,3,4-tri-O-acetyl-6-deoxy-α-d-glucopyranosid-6-yl)-1H-purine-2 
2-Acetamide

3,7-
3,7-Dimethyl-3,7-dihydro-1-(methyl 2,3,4-tri-O-benzyl-6-deoxy-α-d-glucopyranosid-6-yl)-1H-purine-2,6-dione (12)
Obtained (methyl 2,3,4-tri-O-benzyl-α-d-glucopyranosid-6-yl)uracil (15) and 1-(methyl 2,3,4-tri-O-benzyl-6-deoxy-α-d-glucopyranosid-6-yl) , 1 H, H-6′a, J 6′a,6′b = 14.0), 4.02 (t, 1 H, H-3′, J 2′,3′ = J 3′,4′ = 9.1), 3.81 (br. t, 1 H, H-5′, J 4′,5′~J5′,6′b ), 3.54-3.43  (m, 2 H, H-6′b, H-2′), 3.29-3.19 (4 H, OCH 3 , H-4′, J 4′,5′~J3′,4′~9 .1). , 1 H, H-6 
2,4-Bis-O-
2-Acetamido-9-(methyl 6-deoxy-α-d-glucopyranosid-6-yl)purine (7)
To solution of 2-acetamide-6-chloro-9-(methyl 2,3,4-tri-O-benzyl-6-deoxy-α-d-glucopyranosid-6-yl)purine (5, 45 mg, 0.068 mmol) in anhydrous methanol (15 mL), 10 % Pd/C (one spatula point) was added and the reaction mixture was stirred under hydrogen atmosphere for 72 h. The mixture was then filtered through Celite and the filtrate was concentrated in vacuum. 
General procedure for deacetylation by trifluoroacetic acid (TFA)-mediated hydrolysis leading to deprotected isonucleosides
A solution of acetylated 6′-isonucleoside (30 mg) in aq. TFA (80 %, 2.5 mL) was stirred at 60 °C for 16 h. After co-evaporation of the solvents with toluene, the crude product was purified by column chromatography on silica gel.
9-(Methyl 6-deoxy-α-d-glucopyranosid-6-yl)adenine (10)
Obtained by acid hydrolysis of 9-(methyl 2,3,4-tri-O-acetyl-6-deoxy-α-d-glucopyranosid-6-yl)adenine (8, 30 mg, 0.069 mmol) using TFA (80 %, 2.5 mL). Purification by column chromatography (dichloromethane/ methanol, from 9:1 to 4:1) afforded 9 (21 mg, quant.) as a colorless hygroscopic solid.
= + Obtained by acid hydrolysis of 3,7-dimethyl-3,7-dihydro-1-(methyl 2,3,4-tri-O-acetyl-6-deoxy-α-d-glucopyranosid-6-yl)-1H-purine-2,6-dione (11, 30 mg, 0.062 mmol) using TFA (80 %, 2.5 mL). Purification by column chromatography (from dicloromethane to dichloromethane/methanol, 9:1) afforded 13 ( two most active compounds, 11 and 20, were built using Pymol [55] and geometry optimized using Gaussian 09 [60] at the PBE1PBE/6-31G * level of theory [61] . Atomic point charges for the individual compounds were determined according to the RESP methodology [62] using the same level of theory. These charges were kept during the generation of the input pdbqt files for the ligands via the Autodock graphical interface AutoDockTools [63, 64] , although the charges of the non-polar hydrogens were merged into the corresponding heavy atom. The PDB of the protein, striped of water molecules and co-crystallized inhibitor, was also treated with AutoDockTools. Given their location near the entrance of the binding pocket, residues Tyr124, Trp286, Tyr337, and Tyr341 were considered flexile.
The 
